The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics
ChemMedChem · 26.11.2026 · 21 (22)
DOI: 10.1002/cmdc.70576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 13.11.2026. Verfasst von Huihui Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Tumor Microenvironment, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 138 Literaturangaben. Gefördert von: Natural Science Foundation of Shaanxi Province, Basic Research Program of Shanxi Province.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is significantly constrained in hypoxic tumor microenvironments (TMEs) because conventional Type II photosensitization depends strongly on molecular oxygen for efficient singlet oxygen generation. This limitation has stimulated increasing interest in Type I photosensitizers, which initiate photochemical reactions through electron or hydrogen transfer and can retain reactive oxygen species (ROS)‐generating activity under reduced oxygen availability. In some Type I PDT systems, additional oxygen‐regulating processes can further alleviate local hypoxia, thereby sustaining O 2 − ‐dependent downstream ROS generation while contributing to the modulation of the TME. These properties also support combination strategies with photothermal therapy, immunotherapy, or chemotherapy to enhance therapeutic outcomes. This review systematically examines Type I photosensitizers within a framework linking molecular design, photophysical and photochemical properties, mechanistic pathways, and biomedical applications. Their classification, structure–property relationships, and mechanisms of action are critically examined, with particular emphasis on recent advances in hypoxia‐tolerant PDT, multimodal combination therapy, and imaging‐guided theranostics. Finally, the remaining challenges and future directions are discussed with the aim of facilitating the translation of Type I photosensitizers from fundamental research toward clinical cancer theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- College of Medical Imaging, Shanxi Medical University, Taiyuan, Shanxi, China.
ORCID-Profile: Feifei An
Förderung
- Natural Science Foundation of Shaanxi Province
- Basic Research Program of Shanxi Province
Zitieren
APA
Lu, H., Zhang, J., Zhao, J., Li, Y., An, F., & Chai, Y. (2026). The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70576
Vancouver
Lu H, Zhang J, Zhao J, Li Y, An F, Chai Y. The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70576
BibTeX
@article{Lu2026,
author = {Lu, Huihui and Zhang, Jingjing and Zhao, Jiayao and Li, Yanan and An, Feifei and Chai, Yichao},
title = {The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {22},
doi = {10.1002/cmdc.70576}
}
EUVIMED